Fukuokaya W, Mori K, Yanagisawa T, Urabe F, Rajwa P, Briganti A, Shariat SF, Matsubara N, Kimura T, Hirakawa A. Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration-sensitive prostate cancer. Cancer. 2025 Apr 1;131(7):e35819. doi: 10.1002/cncr.35819. PMID: 40106307; PMCID: PMC11922167.